Sort
85,873 grants matching “alzheimers”
Early detection of Alzheimer's (MCI stage): Analysis of plasma cell-free miRNA
$779,335Samuil R Umansky · Diamir, Llc · R44 · FY2016 · AG
Active Help, Immune Function and Health Outcomes in Alzheimer's Caregivers
$779,333Stephanie L Brown · State University New York Stony Brook · R01 · FY2022 · AG
Development of a nanoparticle-based gene editing technology for neurological applications
$779,310Krystof S Bankiewicz · Ohio State University · UG3 · FY2019 · NS
Risk Evaluation and Education for Alzheimer's Disease
$779,277Boston University Medical Campus · R01 · FY2005 · HG
Immune cell activation and associated blood brain barrier changes across different stages of Alzheimer's disease
$779,250Jagan Ayyappan Pillai · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · AG
Negotiation Training to Optimize Caregiver Communication in Alzheimer's Disease
$779,218Lee A Lindquist · Northwestern University At Chicago · R01 · FY2021 · AG
Personalized genetic profiles of risk and resilience in Alzheimer's and vascular diseases
$779,208Alexander M Kulminski · Duke University · R01 · FY2021 · AG
Sleep Impairment: A Mechanism Explaining Neuropsychiatric Symptoms in Alzheimer's
$779,205Matthew Paul Walker · University Of California Berkeley · R01 · FY2022 · MH
SBIR Phase II: All-Carbon, Chemically Cross-Linked 3D Nano Assemblies for Liquid Chromatography
$779,175Balaji Sitharaman · Millennial Materials And Devices Inc · · FY2019 · TIP
Identifying Digital Phenotypes of Risk for Alzheimer's Disease and Related Dementias Among Hispanics/Latinos
$779,163Raeanne Cristine Moore · University Of California, San Diego · R01 · FY2023 · AG
MRI markers of brain aging and risk factors for cognitive decline in older African Americans
$779,147Lisa L Barnes · Rush University Medical Center · R01 · FY2018 · AG
A National Analysis of Observation Care Among Medicare Beneficiaries with Alzheimer's Disease and Related Dementias
$779,135Laura G Burke · Beth Israel Deaconess Medical Center · R56 · FY2022 · AG
Alzheimer's Disease Risk and Ethnic Factors: The Case of Arab Americans
$779,094Kristine J Ajrouch · University Of Michigan At Ann Arbor · R01 · FY2021 · AG
TRiPOD: Toward Reusable Phenotypes in Observational Data for AD/ADRD - managing definitions and correcting bias
$779,072Yong Chen · University Of Pennsylvania · R01 · FY2024 · AG
Feedback amplification between Retrotransposons/endogenous retroviruses and TDP-43 in Alzheimers related dementias
$779,069Joshua T Dubnau · State University New York Stony Brook · R01 · FY2023 · AG
Feedback amplification between Retrotransposons/endogenous retroviruses and TDP-43 in Alzheimers related dementias
$779,069Joshua T Dubnau · State University New York Stony Brook · R01 · FY2024 · AG
Peripheral and brain levels of advanced glycation end products AGEs and incident Alzheimers disease and neuropathology
$779,023Michal Schnaider Beeri · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · AG
Clinical Core
$779,002Jeff Douglas Williamson · Wake Forest University Health Sciences · P30 · FY2024 · AG
Clinical Core
$779,002Jeff Douglas Williamson · Wake Forest University Health Sciences · P30 · FY2022 · AG
Clinical Core
$779,002Jeff Douglas Williamson · Wake Forest University Health Sciences · P30 · FY2023 · AG
Clinical Core
$779,002Jeff Douglas Williamson · Wake Forest University Health Sciences · P30 · FY2025 · AG
Clinical Core
$779,002Jeff Douglas Williamson · Wake Forest University Health Sciences · P30 · FY2021 · AG
Closing the gap between observational research and randomized trials for prevention of Alzheimer's Disease and dementia
$778,984Medellena Maria Glymour · University Of California, San Francisco · R01 · FY2019 · AG
Multi-timescale process models to disentangle subtle cognitive decline and learning effects
$778,936Zita Oravecz · Pennsylvania State University, The · R01 · FY2024 · AG
Emory Alzheimer's Disease Center
$778,844Allan I Levey · Emory University · P50 · FY2019 · AG